Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

100.61

+2.31 (2.35%)

At close: Sep 10, 2026, 4:00 PM EDT

102.00

+1.39 (1.38%)

Pre-market: Sep 11, 2026, 7:16 AM EDT

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,533	4,083	1,985	1,376	719	486
Market Cap Growth	67.38%	105.67%	44.25%	91.51%	47.79%	-4.80%
Enterprise Value	6,857	4,026	2,018	1,378	535	299
Last Close Price	100.61	78.99	41.35	29.52	19.50	15.95

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	10.57	7.83	5.89	7.38	9.32	25.41
PB Ratio	-	12.97	8.80	5.53	5.06	4.04
P/TBV Ratio	-	75.93	-	-	8.65	4.79
P/FCF Ratio	-	74.40	212.71	-	-	-
P/OCF Ratio	-	73.13	192.25	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	11.10	7.72	5.99	7.39	6.95	15.62
EV/EBITDA Ratio	-	1909.74	-	-	-	-
EV/FCF Ratio	-	73.36	216.27	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-73.21	1.01	1.41	1.24	0.02	0.02
Debt / EBITDA Ratio	-	70.86	-	-	-	-
Debt / FCF Ratio	-	5.82	34.05	-	-	-
Net Debt / Equity Ratio	-31.15	-0.20	0.17	0.09	-1.05	-1.28
Net Debt / EBITDA Ratio	-4.62	-30.30	-0.58	-0.22	1.17	0.89
Net Debt / FCF Ratio	-1.42	-1.16	4.01	-0.31	1.24	1.16
Asset Turnover	0.70	0.69	0.51	0.37	0.24	0.07
Inventory Turnover	4.64	4.24	3.65	3.38	3.50	-
Quick Ratio	2.62	2.46	2.83	4.07	2.72	3.76
Current Ratio	2.86	2.67	3.10	4.45	2.94	3.91
Return on Equity (ROE)	-702.97%	-8.65%	-37.08%	-83.65%	-103.46%	-57.47%
Return on Assets (ROA)	-6.79%	-1.83%	-8.31%	-13.65%	-25.33%	-40.48%
Return on Capital Employed (ROCE)	-11.70%	-3.50%	-16.10%	-19.50%	-45.50%	-68.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-13.17%	-0.57%	-4.43%	-11.88%	-18.88%	-17.27%
FCF Yield	-3.50%	1.34%	0.47%	-5.16%	-16.76%	-27.31%
Buyback Yield / Dilution	-15.36%	-5.63%	-16.23%	-20.31%	-12.07%	-20.08%

SEC Filings: 10-K · 10-Q